Katherine A. Guthrie

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Edgar Ben‐Josef, Katherine A. Guthrie, Anthony B. El-Khoueiry et al. · Journal of Clinical Oncology · 2015 · 395 citations · Full text

Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral Therapy

W. Garrett Nichols, Katherine A. Guthrie, Lawrence Corey et al. · Clinical Infectious Diseases · 2004 · 383 citations · Full text

Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)

Scott Kopetz, Katherine A. Guthrie, Van K. Morris et al. · Journal of Clinical Oncology · 2020 · 381 citations · Full text

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip et al. · Journal of Clinical Oncology · 2019 · 314 citations · Full text

Surgery-Related Factors and Local Recurrence of Wilms Tumor in National Wilms Tumor Study 4

Robert C. Shamberger, Katherine A. Guthrie, Michael L. Ritchey et al. · Annals of Surgery · 1999 · 307 citations